Early Onset Preeclampsia Dinner Symposium
Feb. 4, 2016 7 - 9:30pm
Early Onset
Preeclampsia (EOP) defined as Preeclampsia arising before 34 weeks gestational
age is a rare but extremely critical condition occurring in about 0.3% of all pregnancies.
Growth (% change) in the incidence of EOP is outpacing other types of
preeclampsia, and other modern public health challenges including diabetes and
Alzheimer’s disease. EOP is particularly vexing as it is one of the leading
causes of prematurity in the United States and Worldwide. While expectant
management in selected patients has now become “standard of care” many controversies
regarding the diagnosis and management remain. In addition, many new therapies
are currently in development which could ultimately impact medical practice of
this difficult to manage condition.
Topics Include:
· Introductions and Learning Objectives - Baha Sibai, MD
· Epidemiology of EOP and Natural History of Expectant Management -Amelia Sutton, MD
· Burden of EOP: Mother and Newborn Outcomes - Michael Paidas, MD
· Biomarkers to Predict Adverse Outcomes During Expectant Management - TBA
· Novel Therapies for the Treatment of EOP - Baha Sibai, MD
· Open Discussion on Key Issues in Expectant Management – Faculty and Audience
This program is supported by a generous, unrestricted educational grant from rEVO Biologics.
The content of this non-CME educational symposium was developed independently with the goal of ensuring regulatory compliance to support initiatives that accelerate the translation of clinical science into quality patient care.
132 people registered | 0 spots left
Price: $0.00